Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 1
2006 9
2007 8
2008 2
2009 9
2010 5
2011 3
2012 8
2013 6
2014 7
2015 20
2016 9
2017 6
2018 11
2019 20
2020 29
2021 5
Text availability
Article attribute
Article type
Publication date

Search Results

147 results
Results by year
Filters applied: . Clear all
Page 1
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial.
Harris PNA, Tambyah PA, Lye DC, Mo Y, Lee TH, Yilmaz M, Alenazi TH, Arabi Y, Falcone M, Bassetti M, Righi E, Rogers BA, Kanj S, Bhally H, Iredell J, Mendelson M, Boyles TH, Looke D, Miyakis S, Walls G, Al Khamis M, Zikri A, Crowe A, Ingram P, Daneman N, Griffin P, Athan E, Lorenc P, Baker P, Roberts L, Beatson SA, Peleg AY, Harris-Brown T, Paterson DL; MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN). Harris PNA, et al. Among authors: peleg ay. JAMA. 2018 Sep 11;320(10):984-994. doi: 10.1001/jama.2018.12163. JAMA. 2018. PMID: 30208454 Free PMC article. Clinical Trial.
The Mechanisms of Disease Caused by Acinetobacter baumannii.
Morris FC, Dexter C, Kostoulias X, Uddin MI, Peleg AY. Morris FC, et al. Among authors: peleg ay. Front Microbiol. 2019 Jul 17;10:1601. doi: 10.3389/fmicb.2019.01601. eCollection 2019. Front Microbiol. 2019. PMID: 31379771 Free PMC article. Review.
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
McMahon JH, Udy A, Peleg AY. McMahon JH, et al. Among authors: peleg ay. N Engl J Med. 2020 Sep 3;383(10):992-993. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10. N Engl J Med. 2020. PMID: 32649075 No abstract available.
Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial.
Harris PN, Peleg AY, Iredell J, Ingram PR, Miyakis S, Stewardson AJ, Rogers BA, McBryde ES, Roberts JA, Lipman J, Athan E, Paul SK, Baker P, Harris-Brown T, Paterson DL. Harris PN, et al. Among authors: peleg ay. Trials. 2015 Jan 27;16:24. doi: 10.1186/s13063-014-0541-9. Trials. 2015. PMID: 25623485 Free PMC article. Clinical Trial.
Bacteriophage-resistant Acinetobacter baumannii are resensitized to antimicrobials.
Gordillo Altamirano F, Forsyth JH, Patwa R, Kostoulias X, Trim M, Subedi D, Archer SK, Morris FC, Oliveira C, Kielty L, Korneev D, O'Bryan MK, Lithgow TJ, Peleg AY, Barr JJ. Gordillo Altamirano F, et al. Among authors: peleg ay. Nat Microbiol. 2021 Feb;6(2):157-161. doi: 10.1038/s41564-020-00830-7. Epub 2021 Jan 11. Nat Microbiol. 2021. PMID: 33432151
147 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page